Shorter disease‐free survival (hazard ratio = 1.8; p = 0.0099) and poorer overall survival (hazard ratio = 2; p = 0.012) were recorded for patients characterized by high levels of CFDP1 expression and experiencing HCC. The gene discussed is CFDP1; the disease is hepatocellular carcinoma.